What is Fractyl Health, Inc. Common Stock?
, a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 10.88M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 164,516 shares $40k |
| 3-6months | 0 | 5171,493 shares $127k |
| 6-9months | 0 | 0 |
| 9-12months | 0 | 110,416 shares $20k |